Pages
123 Results for Patient Experience
-
Therapy Access
-
Health System Specialty Pharmacy Supports Access and Adherence for GLP-1 Receptor Agonists for Patients with Obesity
Insights
Health System Specialty Pharmacy Supports Access and Adherence for GLP-1 Receptor Agonists for Patients with Obesity
This study assesses the impact of an integrated health system specialty pharmacy model on GLP-1 RA access and adherence in adult patients with obesity.
-
Patient Perception of Treatment Experience Observed During Routine Specialty Pharmacy Interactions for ATTR-CM
Insights
Patient Perception of Treatment Experience Observed During Routine Specialty Pharmacy Interactions for ATTR-CM
This study assesses the patient perception of treatment experience observed during routine specialty pharmacy interactions among tafamidis-treated ATTR-CM patients.
-
Pharmacist Interventions Associated with a Cardiac Amyloidosis Patient Management Program
Insights
Pharmacist Interventions Associated with a Cardiac Amyloidosis Patient Management Program
This study assesses the pharmacist impact within an ATTR-CM specialty program by characterizing documented interventions and associated outcomes.
-
Two-year Impact of a Targeted Workflow to Reengage Hard to Reach Patients Within a Health System Specialty Pharmacy
Insights
Two-year Impact of a Targeted Workflow to Reengage Hard to Reach Patients Within a Health System Specialty Pharmacy
This study assesses the impact of a structured approach to increase engagement with health system specialty pharmacy patients who were previously lost to follow up.
-
Shields Health Solutions
Pages
Shields Health Solutions
-
Solutions
Pages
Solutions
-
Discontinuation of GLP-1 and GLP-1/GIP Receptor Agonists Among Adults with Type 2 Diabetes, Overweight or Obesity
Insights
Discontinuation of GLP-1 and GLP-1/GIP Receptor Agonists Among Adults with Type 2 Diabetes, Overweight or Obesity
This poster explores the ability of integrated health system specialty pharmacies to mitigate barriers faced by patients taking Glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
-
Recombinant Human Growth Hormone Therapy Clinical Outcomes at an Integrated Health System Specialty Pharmacy
Insights
Recombinant Human Growth Hormone Therapy Clinical Outcomes at an Integrated Health System Specialty Pharmacy
This study assess the impact of a health system specialty pharmacy program on operational and clinical outcomes for patients on hGH.
-
Shields Health Solutions Brings Integrated Specialty Pharmacy Services to Baptist Health in Jacksonville
News
Shields Health Solutions Brings Integrated Specialty Pharmacy Services to Baptist Health in Jacksonville
The onsite specialty pharmacy will streamline access to medications, enhance care coordination, and improve patient outcomes.
-
Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters
Insights
Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters
With the right partner, you can accelerate your specialty pharmacy program’s potential while retaining full ownership and staying true to your mission. Learn how.
-
Technology
Pages
Technology